KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Total Current Liabilities (2016 - 2025)

Sarepta Therapeutics has reported Total Current Liabilities over the past 15 years, most recently at $1.1 billion for Q4 2025.

  • Quarterly results put Total Current Liabilities at $1.1 billion for Q4 2025, up 49.69% from a year ago — trailing twelve months through Dec 2025 was $1.1 billion (up 49.69% YoY), and the annual figure for FY2025 was $1.1 billion, up 49.69%.
  • Total Current Liabilities for Q4 2025 was $1.1 billion at Sarepta Therapeutics, up from $921.4 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for SRPT hit a ceiling of $1.1 billion in Q4 2025 and a floor of $364.7 million in Q1 2021.
  • Median Total Current Liabilities over the past 5 years was $604.3 million (2022), compared with a mean of $612.5 million.
  • Biggest five-year swings in Total Current Liabilities: soared 61.45% in 2022 and later fell 25.24% in 2023.
  • Sarepta Therapeutics' Total Current Liabilities stood at $452.7 million in 2021, then surged by 36.86% to $619.6 million in 2022, then grew by 5.5% to $653.7 million in 2023, then increased by 11.94% to $731.7 million in 2024, then surged by 49.69% to $1.1 billion in 2025.
  • The last three reported values for Total Current Liabilities were $1.1 billion (Q4 2025), $921.4 million (Q3 2025), and $919.9 million (Q2 2025) per Business Quant data.